Wenying Yu Selected Research

Wenying Yu Research Topics

Disease

19	Neoplasms (Cancer) 10/2021 - 05/2011
4	Breast Neoplasms (Breast Cancer) 10/2021 - 11/2016
3	Triple Negative Breast Neoplasms 05/2021 - 10/2018
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2019
2	Hypoxia (Hypoxemia) 04/2022 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 12/2021 - 03/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 06/2002
1	Starvation 04/2022
1	Leukemia 01/2022
1	Carcinogenesis 10/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Bites and Stings (Sting) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Hyperplasia 01/2021
1	Infections 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 05/2015
1	Medulloblastoma 02/2015
1	Pica (Geophagia) 11/2012
1	Thrombosis (Thrombus) 07/2011
1	Ischemic Stroke 07/2011
1	Rhabdomyosarcoma 07/2011
1	Hepatocellular Carcinoma (Hepatoma) 05/2011

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 10/2021 - 07/2011
7	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2021 - 05/2011
3	cryptotanshinoneIBA 05/2021 - 10/2018
3	Interleukin-6 (Interleukin 6)IBA 03/2016 - 05/2011
2	InterferonsIBA 01/2021 - 02/2015
2	CytokinesIBA 01/2021 - 05/2011
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 07/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2011
1	Protein Kinases (Protein Kinase)IBA 04/2022
1	ethyleneIBA 04/2022
1	Oxygen (Dioxygen)IBA 04/2022
1	Sucrose (Saccharose)IBA 04/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Liposomes (Liposome)IBA 12/2021
1	oridoninIBA 12/2021
1	Histone Deacetylase InhibitorsIBA 10/2021
1	Drug CombinationsIBA 10/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	sacubitrilIBA 01/2021
1	GMP synthase (glutamine-hydrolyzing)IBA 01/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	Cyclic AMP (AMP, Cyclic)IBA 01/2021
1	Alcian BlueIBA 01/2021
1	LBQ657IBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	Interferon Type IIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Periodic AcidIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	SmokeIBA 01/2021
1	Transient Receptor Potential ChannelsIBA 01/2021
1	Phenobarbital (Luminal)FDA Link 05/2020
1	Circular RNAIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Etoposide (VP 16)FDA LinkGeneric 12/2019
1	ProdrugsIBA 12/2019
1	indacaterolIBA 01/2019
1	RNA Splicing FactorsIBA 01/2019
1	Biological ProductsIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 11/2017
1	Indicators and Reagents (Reagents)IBA 11/2017
1	Leucyl Aminopeptidase (Peptidase S)IBA 11/2017
1	Peptide Hydrolases (Proteases)FDA Link 11/2017
1	CurcuminIBA 11/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Monoamine Oxidase (MAO)IBA 05/2015
1	coumarinIBA 05/2015
1	Tacrine (Cognex)FDA Link 05/2015
1	Cholinesterases (Cholinesterase)IBA 05/2015
1	Leukemia Inhibitory FactorIBA 02/2015
1	Epidermal Growth Factor (EGF)IBA 02/2015
1	Peptides (Polypeptides)IBA 02/2015
1	Cisplatin (Platino)FDA LinkGeneric 02/2015
1	Insulin-Like PeptidesIBA 02/2015
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 02/2015
1	ClusterinIBA 01/2014
1	Carbon Nanotubes (Carbon Nanotube)IBA 11/2012
1	ElectrolytesIBA 11/2012
1	AcidsIBA 11/2012
1	3-n-butylphthalide (butylphthalide)IBA 07/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2011
1	SurvivinIBA 07/2011
1	Cyclin D1IBA 07/2011
1	ErbB Receptors (EGF Receptor)IBA 06/2002

Therapy/Procedure

14	Therapeutics 05/2021 - 07/2011
2	Drug Therapy (Chemotherapy) 01/2021 - 12/2019